GlucoTrack, Inc. (GCTK)

USD 0.23

(-5.78%)

Total Liabilities Summary of GlucoTrack, Inc.

  • GlucoTrack, Inc.'s latest annual total liabilities in 2023 was 1.7 Million USD , up 41.39% from previous year.
  • GlucoTrack, Inc.'s latest quarterly total liabilities in 2024 Q2 was 3.89 Million USD , up 125.26% from previous quarter.
  • GlucoTrack, Inc. reported annual total liabilities of 1.2 Million USD in 2022, up 8.83% from previous year.
  • GlucoTrack, Inc. reported annual total liabilities of 1.11 Million USD in 2021, down -31.65% from previous year.
  • GlucoTrack, Inc. reported quarterly total liabilities of 1.73 Million USD for 2024 Q1, up 1.29% from previous quarter.
  • GlucoTrack, Inc. reported quarterly total liabilities of 1.7 Million USD for 2023 Q4, up 4.27% from previous quarter.

Annual Total Liabilities Chart of GlucoTrack, Inc. (2023 - 2011)

Historical Annual Total Liabilities of GlucoTrack, Inc. (2023 - 2011)

Year Total Liabilities Total Liabilities Growth
2023 1.7 Million USD 41.39%
2022 1.2 Million USD 8.83%
2021 1.11 Million USD -31.65%
2020 1.62 Million USD -39.72%
2019 2.69 Million USD -24.36%
2018 3.56 Million USD -80.48%
2017 18.24 Million USD 36.04%
2016 13.41 Million USD 47.31%
2015 9.1 Million USD -18.58%
2014 11.18 Million USD -19.1%
2013 13.81 Million USD 948.79%
2012 1.31 Million USD 8.51%
2011 1.21 Million USD 0.0%

Peer Total Liabilities Comparison of GlucoTrack, Inc.

Name Total Liabilities Total Liabilities Difference
Akoya Biosciences, Inc. 126.59 Million USD 98.651%
AngioDynamics, Inc. 112.08 Million USD 98.476%
AtriCure, Inc. 147.76 Million USD 98.844%
Avinger, Inc. 19.97 Million USD 91.448%
Azenta, Inc. 351.22 Million USD 99.514%
BioLife Solutions, Inc. 75.05 Million USD 97.724%
The Cooper Companies, Inc. 4.1 Billion USD 99.958%
Daxor Corporation 858.75 Thousand USD -98.892%
Ekso Bionics Holdings, Inc. 16.31 Million USD 89.529%
Femasys Inc. 9.4 Million USD 81.836%
Harvard Bioscience, Inc. 64.29 Million USD 97.343%
Hologic, Inc. 4.02 Billion USD 99.958%
ICU Medical, Inc. 2.25 Billion USD 99.924%
Intuitive Surgical, Inc. 2.04 Billion USD 99.916%
KORU Medical Systems, Inc. 8.1 Million USD 78.932%
LeMaitre Vascular, Inc. 48.87 Million USD 96.506%
Innovative Eyewear, Inc. 659.93 Thousand USD -158.813%
Innovative Eyewear, Inc. 659.93 Thousand USD -158.813%
Masimo Corporation 1.67 Billion USD 99.898%
Microbot Medical Inc. 3.82 Million USD 55.358%
Meihua International Medical Technologies Co., Ltd. 25.07 Million USD 93.189%
Merit Medical Systems, Inc. 1.12 Billion USD 99.848%
Nephros, Inc. 3.5 Million USD 51.242%
NovoCure Limited 783.63 Million USD 99.782%
NEXGEL, Inc. 4.78 Million USD 64.335%
NEXGEL, Inc. 4.78 Million USD 64.335%
Singular Genomics Systems, Inc. 86.46 Million USD 98.025%
OraSure Technologies, Inc. 52.17 Million USD 96.726%
Pro-Dex, Inc. 23.34 Million USD 92.683%
Pulse Biosciences, Inc. 16.44 Million USD 89.613%
Predictive Oncology Inc. 6.14 Million USD 72.207%
Precision Optics Corporation, Inc. 6.84 Million USD 75.047%
QuidelOrtho Corporation 3.55 Billion USD 99.952%
Repligen Corporation 853.2 Million USD 99.8%
Sanara MedTech Inc. 29.28 Million USD 94.167%
STAAR Surgical Company 102.73 Million USD 98.338%
Sharps Technology, Inc. 3.85 Million USD 55.694%
Utah Medical Products, Inc. 7.14 Million USD 76.095%
DENTSPLY SIRONA Inc. 4.07 Billion USD 99.958%
Jin Medical International Ltd. 8.92 Million USD 80.861%